Mindfulness Intervention for Fibromyalgia Delivered Through a Smartphone App
Fibroapp
1 other identifier
interventional
54
1 country
1
Brief Summary
The purpose of this pilot feasibility study is to evaluate the effects of a smartphone-based mindfulness intervention (MBI) on pain-related outcomes in individuals with fibromyalgia. This 8-week randomized controlled trial will compare an MBI app group to a control group who completes assessments only through the app. The MBI intervention includes weekly video content focused on mindfulness practice and psychoeducation, combined with daily symptom tracking through the app. Participants in both groups will complete self-report measures at baseline, post-intervention, and follow-ups at 3 and 6 months. The study will enroll up to 100 participants from Brigham and Women's Hospital and the greater Boston area. This pilot study is designed to assess feasibility and explore preliminary effects on outcomes such as pain interference, fibromyalgia symptoms, pain catastrophizing, sleep disturbance, emotional distress, mindfulness, and pain acceptance. Results will be used to inform the design of a future fully powered randomized trial.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 3, 2024
CompletedFirst Submitted
Initial submission to the registry
June 15, 2025
CompletedFirst Posted
Study publicly available on registry
June 24, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2025
CompletedJanuary 29, 2026
January 1, 2026
1.2 years
June 15, 2025
January 28, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Brief Pain Inventory
Assessed using the Brief Pain Inventory - Pain Interference Subscale
Daily for 8-weeks
Secondary Outcomes (6)
Change in Fibromyalgia Symptoms (FIQR)
Weekly for 8-weeks
Change in Pain Catastrophizing (PCS)
Baseline and post (8 weeks)
Pain Acceptance (CPAQ-R)
Baseline and post (8 weeks)
Mindfulness (MAAS)
Baseline and post (8 weeks)
Anxiety and Depression (PROMIS-A/D)
Baseline and post (8 weeks)
- +1 more secondary outcomes
Study Arms (2)
Mindfulness-Based Intervention (MBI)
EXPERIMENTALParticipants in this group will receive access to a smartphone app delivering an 8-week mindfulness-based intervention. The app includes weekly video modules (mindfulness practice and psychoeducation), daily pain tracking, and weekly assessments.
Control
NO INTERVENTIONParticipants in this group will complete the same daily and weekly assessments via the smartphone app but will not have access to the mindfulness or psychoeducation content.
Interventions
Participants will use the smartphone app daily for pain tracking and weekly to engage with mindfulness content and complete additional assessments.
Eligibility Criteria
You may qualify if:
- Adults aged 18 to 65
- Diagnosis of fibromyalgia per Wolfe et al. (2011) criteria
- Stable medication regimen or medication-free
- Fluent in English
- Able to provide informed consent
You may not qualify if:
- Comorbid pain condition more severe than fibromyalgia
- Pregnancy or breastfeeding
- Current psychosis or history of severe psychiatric illness
- Active suicidal ideation
- Participation in another therapeutic trial
- Any condition that may interfere with study compliance as judged by the PI or study coordinator
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The Brigham and Women's Hospital Department of Anesthesiology
Boston, Massachusetts, 02115, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Asimina Lazaridou, PhD
Massachusetts General Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor of Anesthesiology
Study Record Dates
First Submitted
June 15, 2025
First Posted
June 24, 2025
Study Start
May 3, 2024
Primary Completion
August 1, 2025
Study Completion
August 1, 2025
Last Updated
January 29, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share